Portugal

Portugal

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.45 (0.90 - 0.20) 2016 Survey/reported Carvalhana SC , 2016
0.6 (0.10 - 1.60) 2014 Survey/reported Rocha, 2017
0.89 (0.58 - 1.35) 2015 Modelled WHO
1.2 (0.90 - 1.50) 2016 Modelled Razavi-Shearer et al, 2018
1.5 (0.90 - 2) 2014 Survey/reported ECDC
1.02 (0.78 - 1.31) 2013 Modelled Schweitzer et al, 2015
0.91 (0.74 - 1.09) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1 (0.82 - 1.18) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.82 - 1.21) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.85 - 1.21) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.06 (0.86 - 1.24) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.87 - 1.25) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.09 (0.90 - 1.27) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.91 - 1.29) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.12 (0.93 - 1.32) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (0.95 - 1.34) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.15 (0.96 - 1.34) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.97 - 1.35) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.17 (0.97 - 1.35) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.98 - 1.37) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.19 (0.98 - 1.38) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.99 - 1.40) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (1.01 - 1.44) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (1.04 - 1.47) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.27 (1.05 - 1.51) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.05 - 1.54) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.07 - 1.54) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.08 - 1.53) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.07 - 1.53) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.07 - 1.54) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.07 - 1.54) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.08 - 1.55) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.08 - 1.56) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (1.09 - 1.58) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.10 - 1.61) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.37 (1.12 - 1.64) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.17) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.1 (0.05 - 0.17) 2015 Modelled WHO
0.04 (0.02 - 0.05) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.06 (0.04 - 0.08) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.04 - 0.09) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.10) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.05 - 0.11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.05 - 0.11) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.12) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.12) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.13) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.07 - 0.15) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.10 - 0.20) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.13 - 0.27) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.24 (0.16 - 0.35) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.19 - 0.44) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.24 - 0.54) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.30 - 0.66) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.36 - 0.79) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.43 - 0.91) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.48 - 0.99) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.52 - 1.05) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.55 - 1.10) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.58 - 1.15) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.61 - 1.18) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.62 - 1.20) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.1 2017 Survey/reported ECDC
2.22 2010 Survey/reported EMCDDA
3.39 2009 Survey/reported EMCDDA
6.1 2008 Survey/reported EMCDDA
6.9 2007 Survey/reported EMCDDA
5.62 2006 Survey/reported EMCDDA
7.47 2005 Survey/reported EMCDDA
7.45 2004 Survey/reported EMCDDA
7.88 2003 Survey/reported EMCDDA
9.7 2002 Survey/reported EMCDDA
9.4 2001 Survey/reported EMCDDA
13.5 2000 Survey/reported EMCDDA
2 2016 Survey/reported EMCDDA
7 2015 Survey/reported EMCDDA
5.15 2014 Survey/reported EMCDDA
6.52 2013 Survey/reported EMCDDA
4.9 2012 Survey/reported EMCDDA
4.3 2011 Survey/reported EMCDDA
6.8 2010 Survey/reported EMCDDA
2.86 2009 Survey/reported EMCDDA
3.3 2008 Survey/reported EMCDDA
3.2 2007 Survey/reported EMCDDA
3 2006 Survey/reported EMCDDA
3.3 2005 Survey/reported EMCDDA
4.85 2004 Survey/reported EMCDDA
1.97 2009 Survey/reported EMCDDA
2.7 2008 Survey/reported EMCDDA
2.94 2007 Survey/reported EMCDDA
2.88 2006 Survey/reported EMCDDA
1.8 2005 Survey/reported EMCDDA
2.64 2004 Survey/reported EMCDDA
3.06 2003 Survey/reported EMCDDA
7.68 2002 Survey/reported EMCDDA
5.42 2001 Survey/reported EMCDDA
9.64 2000 Survey/reported EMCDDA
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
10.8 (8.10 - 14) 2008 Survey/reported Marques NM et al, 2011
Technical notes

Number of persons living with chronic HBV

National
Download
Value Year Type Source
125,000 (91,000 - 160,000) 2016 Modelled Razavi-Shearer et al, 2018
96,485 (78,360 - 116,117) 2019 Modelled IHME, GBD 2019 (accessed 2020)
98,688 (80,275 - 118,535) 2019 Modelled IHME, GBD 2019 (accessed 2022)
102,078 (83,296 - 120,225) 2018 Modelled IHME, GBD 2019 (accessed 2022)
104,277 (83,749 - 123,334) 2017 Modelled IHME, GBD 2019 (accessed 2022)
106,013 (86,446 - 123,614) 2016 Modelled IHME, GBD 2019 (accessed 2022)
107,910 (87,644 - 126,567) 2015 Modelled IHME, GBD 2019 (accessed 2022)
109,583 (89,344 - 127,872) 2014 Modelled IHME, GBD 2019 (accessed 2022)
111,404 (91,825 - 129,895) 2013 Modelled IHME, GBD 2019 (accessed 2022)
113,218 (93,516 - 132,385) 2012 Modelled IHME, GBD 2019 (accessed 2022)
114,854 (95,520 - 135,060) 2011 Modelled IHME, GBD 2019 (accessed 2022)
116,146 (97,152 - 137,136) 2010 Modelled IHME, GBD 2019 (accessed 2022)
117,167 (98,233 - 137,175) 2009 Modelled IHME, GBD 2019 (accessed 2022)
118,128 (98,736 - 137,626) 2008 Modelled IHME, GBD 2019 (accessed 2022)
119,061 (99,109 - 138,377) 2007 Modelled IHME, GBD 2019 (accessed 2022)
119,996 (99,304 - 139,183) 2006 Modelled IHME, GBD 2019 (accessed 2022)
120,984 (99,313 - 140,458) 2005 Modelled IHME, GBD 2019 (accessed 2022)
122,333 (100,941 - 142,184) 2004 Modelled IHME, GBD 2019 (accessed 2022)
124,090 (102,686 - 144,970) 2003 Modelled IHME, GBD 2019 (accessed 2022)
125,857 (104,382 - 148,132) 2002 Modelled IHME, GBD 2019 (accessed 2022)
127,227 (105,573 - 151,172) 2001 Modelled IHME, GBD 2019 (accessed 2022)
127,815 (104,712 - 153,294) 2000 Modelled IHME, GBD 2019 (accessed 2022)
127,860 (105,908 - 152,240) 1999 Modelled IHME, GBD 2019 (accessed 2022)
127,839 (105,917 - 151,061) 1998 Modelled IHME, GBD 2019 (accessed 2022)
127,729 (105,396 - 150,344) 1997 Modelled IHME, GBD 2019 (accessed 2022)
127,546 (104,548 - 149,693) 1996 Modelled IHME, GBD 2019 (accessed 2022)
127,296 (104,102 - 149,242) 1995 Modelled IHME, GBD 2019 (accessed 2022)
127,249 (103,325 - 149,476) 1994 Modelled IHME, GBD 2019 (accessed 2022)
127,673 (103,080 - 150,120) 1993 Modelled IHME, GBD 2019 (accessed 2022)
128,477 (104,256 - 151,765) 1992 Modelled IHME, GBD 2019 (accessed 2022)
129,588 (104,494 - 153,491) 1991 Modelled IHME, GBD 2019 (accessed 2022)
130,941 (106,121 - 156,136) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.42 (1.87 - 3.13) 2019 Modelled IHME, GBD 2019 (accessed 2020)
4.38 (3.17 - 5.85) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4.47 (3.26 - 5.97) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.48 (3.29 - 5.95) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.48 (3.32 - 5.93) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.29 (3.17 - 5.69) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.32 (3.22 - 5.64) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.36 (3.29 - 5.65) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.18 (3.17 - 5.46) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.27 (3.22 - 5.55) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (2.95 - 5.11) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.05 (3.07 - 5.29) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (2.77 - 4.82) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (2.88 - 5) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (2.69 - 4.69) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.39 (2.58 - 4.44) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.29 (2.50 - 4.30) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.14 (2.39 - 4.08) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.27 - 3.84) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.79 (2.13 - 3.64) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.66 (2.04 - 3.44) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.98 - 3.33) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.51 (1.93 - 3.25) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (1.89 - 3.15) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.36 (1.82 - 3.04) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.86 - 3.09) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.33 (1.78 - 2.99) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.38 (1.83 - 3.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.84 - 3.10) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.85 - 3.09) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.42 (1.87 - 3.13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
587 2016 Modelled WHO
444 (321 - 593) 1990 Modelled IHME, GBD 2019 (accessed 2022)
454 (331 - 605) 1991 Modelled IHME, GBD 2019 (accessed 2022)
455 (334 - 604) 1992 Modelled IHME, GBD 2019 (accessed 2022)
456 (338 - 604) 1993 Modelled IHME, GBD 2019 (accessed 2022)
438 (323 - 582) 1994 Modelled IHME, GBD 2019 (accessed 2022)
443 (331 - 579) 1995 Modelled IHME, GBD 2019 (accessed 2022)
449 (339 - 583) 1996 Modelled IHME, GBD 2019 (accessed 2022)
442 (333 - 575) 1997 Modelled IHME, GBD 2019 (accessed 2022)
435 (330 - 569) 1998 Modelled IHME, GBD 2019 (accessed 2022)
425 (322 - 555) 1999 Modelled IHME, GBD 2019 (accessed 2022)
411 (311 - 539) 2000 Modelled IHME, GBD 2019 (accessed 2022)
389 (295 - 514) 2002 Modelled IHME, GBD 2019 (accessed 2022)
403 (305 - 530) 2001 Modelled IHME, GBD 2019 (accessed 2022)
380 (288 - 501) 2003 Modelled IHME, GBD 2019 (accessed 2022)
363 (276 - 475) 2004 Modelled IHME, GBD 2019 (accessed 2022)
321 (245 - 414) 2007 Modelled IHME, GBD 2019 (accessed 2022)
338 (257 - 438) 2006 Modelled IHME, GBD 2019 (accessed 2022)
353 (268 - 461) 2005 Modelled IHME, GBD 2019 (accessed 2022)
301 (230 - 393) 2008 Modelled IHME, GBD 2019 (accessed 2022)
287 (220 - 371) 2009 Modelled IHME, GBD 2019 (accessed 2022)
277 (213 - 359) 2010 Modelled IHME, GBD 2019 (accessed 2022)
271 (209 - 351) 2011 Modelled IHME, GBD 2019 (accessed 2022)
265 (204 - 340) 2012 Modelled IHME, GBD 2019 (accessed 2022)
260 (201 - 333) 2013 Modelled IHME, GBD 2019 (accessed 2022)
254 (195 - 327) 2014 Modelled IHME, GBD 2019 (accessed 2022)
250 (192 - 321) 2015 Modelled IHME, GBD 2019 (accessed 2022)
256 (196 - 329) 2016 Modelled IHME, GBD 2019 (accessed 2022)
258 (197 - 332) 2017 Modelled IHME, GBD 2019 (accessed 2022)
257 (197 - 330) 2018 Modelled IHME, GBD 2019 (accessed 2022)
258 (199 - 333) 2019 Modelled IHME, GBD 2019 (accessed 2022)
258 (199 - 333) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
4 (2 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2012 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2019 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
97 2019 Survey/reported WHO/UNICEF
97 2018 Survey/reported WHO/UNICEF
97 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
95 2009 Survey/reported WHO/UNICEF
95 2008 Survey/reported WHO/UNICEF
95 2007 Survey/reported WHO/UNICEF
91 2006 Survey/reported WHO/UNICEF
86 2005 Survey/reported WHO/UNICEF
86 2004 Survey/reported WHO/UNICEF
84 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
82 2001 Survey/reported WHO/UNICEF
64 2000 Survey/reported WHO/UNICEF
97 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2019 Survey/reported WHO/UNICEF
99 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
63 (57 - 72) 2015 Survey/reported EMCDDA, 2017
108 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
45 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
Source:
HBV elimination goal
2030
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2000
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
2030
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.8 (0.70 - 1.10) 2015 Modelled Blach et al, 2017
1.02 (0.84 - 1.23) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.83 - 1.23) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.83 - 1.23) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.82 - 1.21) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.21) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.20) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.20) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.20) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.19) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.19) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.19) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.18) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.18) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.80 - 1.17) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.18) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.18) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.20) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.79 - 1.16) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
36.5 2010 Survey/reported EMCDDA
28.68 2009 Survey/reported EMCDDA
33.5 2008 Survey/reported EMCDDA
38.68 2007 Survey/reported EMCDDA
41.73 2006 Survey/reported EMCDDA
38.8 2005 Survey/reported EMCDDA
44.49 2004 Survey/reported EMCDDA
45.14 2003 Survey/reported EMCDDA
63.96 2002 Survey/reported EMCDDA
44.72 2001 Survey/reported EMCDDA
48.88 2000 Survey/reported EMCDDA
82.2 2016 Survey/reported EMCDDA
83.5 2015 Survey/reported EMCDDA
84.39 2014 Survey/reported EMCDDA
84.3 2013 Survey/reported EMCDDA
83.78 2012 Survey/reported EMCDDA
82.16 2011 Survey/reported EMCDDA
83.18 2010 Survey/reported EMCDDA
83.13 2009 Survey/reported EMCDDA
84.5 2008 Survey/reported EMCDDA
82.3 2007 Survey/reported EMCDDA
84.8 2006 Survey/reported EMCDDA
84.2 2005 Survey/reported EMCDDA
85.1 2004 Survey/reported EMCDDA
39.94 2009 Survey/reported EMCDDA
41 2008 Survey/reported EMCDDA
43.7 2007 Survey/reported EMCDDA
43.21 2006 Survey/reported EMCDDA
45.78 2005 Survey/reported EMCDDA
49.58 2004 Survey/reported EMCDDA
48 2003 Survey/reported EMCDDA
51.3 2002 Survey/reported EMCDDA
50.9 2001 Survey/reported EMCDDA
48.8 2000 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.25 (0.21 - 0.34) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.2 (0.40 - 2.50) 2017 Survey/reported Rocha, 2017
0.54 (0.20 - 0.90) 2016 Survey/reported Carvalhana SC et al, 2016
1.8 (0.50 - 2.90) 2014 Modelled Gower et al, 2014
0.5 (0.20 - 0.90) 2014 Survey/reported ECDC
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
87.7 (80.50 - 95) 2016 Modelled Degenhardt L et al, 2017
84.3 (80.40 - 87.70) 2013 Survey/reported EMCDDA
81.5 2017 Survey/reported ECDC
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
34.4 (26.90 - 42.60) 2008 Survey/reported Marques NM et al, 2011
Technical notes

Number of persons living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
89,000 (74,000 - 120,000) 2015 Modelled Blach et al, 2017
93,742 (77,184 - 114,149) 1990 Modelled IHME, GBD 2019 (accessed 2022)
93,941 (77,614 - 114,124) 1991 Modelled IHME, GBD 2019 (accessed 2022)
94,165 (78,028 - 113,553) 1992 Modelled IHME, GBD 2019 (accessed 2022)
94,479 (78,300 - 113,989) 1993 Modelled IHME, GBD 2019 (accessed 2022)
94,906 (78,401 - 114,403) 1994 Modelled IHME, GBD 2019 (accessed 2022)
95,484 (78,965 - 115,521) 1995 Modelled IHME, GBD 2019 (accessed 2022)
95,985 (79,462 - 115,602) 1996 Modelled IHME, GBD 2019 (accessed 2022)
96,193 (79,409 - 115,992) 1997 Modelled IHME, GBD 2019 (accessed 2022)
96,295 (79,169 - 115,945) 1998 Modelled IHME, GBD 2019 (accessed 2022)
96,401 (78,959 - 116,511) 1999 Modelled IHME, GBD 2019 (accessed 2022)
96,693 (79,237 - 117,247) 2000 Modelled IHME, GBD 2019 (accessed 2022)
97,159 (79,844 - 117,707) 2001 Modelled IHME, GBD 2019 (accessed 2022)
97,528 (80,267 - 117,620) 2002 Modelled IHME, GBD 2019 (accessed 2022)
97,863 (80,594 - 118,084) 2003 Modelled IHME, GBD 2019 (accessed 2022)
98,215 (81,079 - 118,746) 2004 Modelled IHME, GBD 2019 (accessed 2022)
98,635 (81,106 - 119,513) 2005 Modelled IHME, GBD 2019 (accessed 2022)
99,071 (81,597 - 120,188) 2006 Modelled IHME, GBD 2019 (accessed 2022)
99,370 (81,836 - 120,775) 2007 Modelled IHME, GBD 2019 (accessed 2022)
99,624 (81,859 - 121,045) 2008 Modelled IHME, GBD 2019 (accessed 2022)
99,870 (81,920 - 121,620) 2009 Modelled IHME, GBD 2019 (accessed 2022)
100,168 (82,068 - 121,505) 2010 Modelled IHME, GBD 2019 (accessed 2022)
100,476 (82,316 - 121,990) 2011 Modelled IHME, GBD 2019 (accessed 2022)
100,635 (82,982 - 122,270) 2012 Modelled IHME, GBD 2019 (accessed 2022)
100,767 (82,667 - 122,945) 2013 Modelled IHME, GBD 2019 (accessed 2022)
100,916 (82,419 - 123,045) 2014 Modelled IHME, GBD 2019 (accessed 2022)
101,141 (82,588 - 123,537) 2015 Modelled IHME, GBD 2019 (accessed 2022)
101,890 (83,548 - 123,651) 2016 Modelled IHME, GBD 2019 (accessed 2022)
102,743 (84,667 - 124,862) 2017 Modelled IHME, GBD 2019 (accessed 2022)
103,205 (85,176 - 125,138) 2018 Modelled IHME, GBD 2019 (accessed 2022)
102,270 (84,036 - 123,899) 2019 Modelled IHME, GBD 2019 (accessed 2020)
103,292 (84,982 - 124,901) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
5,600 (4,700 - 7,600) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
7.22 (5.74 - 8.81) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.98 (5.33 - 9.24) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.48 - 9.43) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7.1 (5.50 - 9.32) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.51 - 9.27) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.85 (5.30 - 8.83) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.91 (5.37 - 8.90) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.98 (5.47 - 8.90) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.86 (5.38 - 8.70) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.79 (5.33 - 8.57) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.59 (5.21 - 8.29) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.72 (5.29 - 8.47) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.41 (5.10 - 8.09) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.58 (5.25 - 8.28) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.38 (5.09 - 8.04) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.26 (5 - 7.86) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.27 (5 - 7.84) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.27 (5.01 - 7.83) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.36 (5.09 - 7.93) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.42 (5.17 - 7.99) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.54 (5.30 - 8.13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6.63 (5.37 - 8.21) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6.7 (5.43 - 8.24) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6.77 (5.49 - 8.32) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6.83 (5.55 - 8.35) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6.85 (5.56 - 8.36) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6.86 (5.51 - 8.40) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7.05 (5.67 - 8.62) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.73 - 8.77) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7.15 (5.73 - 8.75) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7.22 (5.74 - 8.81) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
661 2016 Modelled WHO
769 (611 - 938) 2019 Modelled IHME, GBD 2019 (accessed 2022)
769 (611 - 939) 2019 Modelled IHME, GBD 2019 (accessed 2020)
764 (612 - 934) 2018 Modelled IHME, GBD 2019 (accessed 2022)
762 (613 - 939) 2017 Modelled IHME, GBD 2019 (accessed 2022)
756 (608 - 924) 2016 Modelled IHME, GBD 2019 (accessed 2022)
737 (592 - 903) 2015 Modelled IHME, GBD 2019 (accessed 2022)
737 (598 - 899) 2014 Modelled IHME, GBD 2019 (accessed 2022)
736 (598 - 900) 2013 Modelled IHME, GBD 2019 (accessed 2022)
730 (592 - 897) 2012 Modelled IHME, GBD 2019 (accessed 2022)
723 (586 - 889) 2011 Modelled IHME, GBD 2019 (accessed 2022)
716 (580 - 887) 2010 Modelled IHME, GBD 2019 (accessed 2022)
705 (572 - 878) 2009 Modelled IHME, GBD 2019 (accessed 2022)
693 (558 - 862) 2008 Modelled IHME, GBD 2019 (accessed 2022)
685 (548 - 854) 2007 Modelled IHME, GBD 2019 (accessed 2022)
675 (539 - 843) 2006 Modelled IHME, GBD 2019 (accessed 2022)
673 (537 - 842) 2005 Modelled IHME, GBD 2019 (accessed 2022)
670 (535 - 842) 2004 Modelled IHME, GBD 2019 (accessed 2022)
681 (543 - 859) 2003 Modelled IHME, GBD 2019 (accessed 2022)
683 (543 - 861) 2002 Modelled IHME, GBD 2019 (accessed 2022)
698 (557 - 877) 2001 Modelled IHME, GBD 2019 (accessed 2022)
695 (549 - 874) 2000 Modelled IHME, GBD 2019 (accessed 2022)
705 (555 - 888) 1999 Modelled IHME, GBD 2019 (accessed 2022)
708 (555 - 893) 1998 Modelled IHME, GBD 2019 (accessed 2022)
711 (558 - 902) 1997 Modelled IHME, GBD 2019 (accessed 2022)
720 (564 - 918) 1996 Modelled IHME, GBD 2019 (accessed 2022)
709 (551 - 913) 1995 Modelled IHME, GBD 2019 (accessed 2022)
699 (542 - 902) 1994 Modelled IHME, GBD 2019 (accessed 2022)
725 (561 - 944) 1993 Modelled IHME, GBD 2019 (accessed 2022)
721 (558 - 946) 1992 Modelled IHME, GBD 2019 (accessed 2022)
722 (556 - 956) 1991 Modelled IHME, GBD 2019 (accessed 2022)
708 (540 - 937) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
10 (8 - 13) 1990 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1991 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 1992 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 1994 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 1995 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 22) 1996 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 1997 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 1998 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 25) 1999 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2000 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 28) 2001 Modelled IHME, GBD 2019 (accessed 2022)
21 (15 - 27) 2002 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 29) 2004 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2003 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 30) 2005 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 32) 2006 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 32) 2007 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 34) 2008 Modelled IHME, GBD 2019 (accessed 2022)
28 (21 - 36) 2009 Modelled IHME, GBD 2019 (accessed 2022)
30 (23 - 38) 2010 Modelled IHME, GBD 2019 (accessed 2022)
32 (24 - 40) 2011 Modelled IHME, GBD 2019 (accessed 2022)
35 (26 - 44) 2013 Modelled IHME, GBD 2019 (accessed 2022)
33 (25 - 42) 2012 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 45) 2014 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 46) 2015 Modelled IHME, GBD 2019 (accessed 2022)
37 (28 - 46) 2016 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 45) 2017 Modelled IHME, GBD 2019 (accessed 2022)
35 (26 - 45) 2018 Modelled IHME, GBD 2019 (accessed 2022)
35 (26 - 44) 2019 Modelled IHME, GBD 2019 (accessed 2022)
39 (29 - 48) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
2,732 2017 Survey/reported ECDC, 2019
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
63 (57 - 72) 2015 Survey/reported EMCDDA, 2017
108 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
45 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
Source:
HBV elimination goal
2030
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2000
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
2030
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
2030
HCV elimination goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
0.97 (%)
2019
(0.79 - 1.17(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
0.96 (%)
2019
(0.79 - 1.16(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

HBV (HBsAg+)
1.45 (%)
2016
(0.9 - 0.2(%))
Carvalhana SC , 2016
HCV (anti-HCV)
1.2 (%)
2017
(0.4 - 2.5(%))
Rocha, 2017

Hepatitis related deaths (national)

Modelled

HBV
258
2019
(199 - 333)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
769
2019
(611 - 938)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.02 (%)
2020, latest modelled
(0.02 - 0.03(%))
WHO

Prevalence PWID

HCV
81.50 (%)
2017, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
97 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
108
2017
ECDC
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Download National Hepatitis Elimination Profile (N-HEP)

Latest news

View all
group signing a document
group photo
Previous Next

News

Resources

Programs

Partners